Derwood, MD, United States of America

Nadejda Soukhareva

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nadejda Soukhareva: Innovator in Pharmaceutical Compositions

Introduction

Nadejda Soukhareva is a prominent inventor based in Derwood, MD (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of neoplastic conditions and scleroderma. With a total of 2 patents, her work has the potential to impact various medical applications.

Latest Patents

Soukhareva's latest patents include formulations of polyalkylene oxide-asparaginase and methods of making and using the same. This invention encompasses polyalkylene oxide-asparaginase compositions, which may include a lyophilized storage stable composition. The compositions are designed for use in treating neoplastic conditions. Additionally, she has developed compositions and methods for treating or ameliorating fibrosis, systemic sclerosis, and scleroderma. These innovations involve Adenosine Deaminase (ADA) and related pharmaceutical compositions aimed at preventing and treating scleroderma-associated vasculopathy.

Career Highlights

Throughout her career, Nadejda has worked with notable companies such as Servier IP UK Limited and Leadiant Biosciences Ltd. Her expertise in pharmaceutical formulations has positioned her as a key player in the industry.

Collaborations

Nadejda has collaborated with esteemed colleagues, including Gianfranco Fornasini and Christopher Phillips. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Nadejda Soukhareva's innovative work in pharmaceutical compositions demonstrates her commitment to advancing medical treatments. Her contributions are poised to make a significant impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…